Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.42 |
| ▸ | ABCC1 | P33527 | 5/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.38 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL5646328 | 0.93 | CRHBP (0.49) | CRHBPCRHR2ABCB1ABCC1THRB | |
| Sulfuric Acid SCHEMBL11883875 | 0.77 | TDP1 (0.49) | MEN1KMT2ATDP1MAPTALDH1A1 | |
| Sulfuric Acid SCHEMBL7560191 | 0.72 | ACLY (0.46) | ACLY | |
| SCHEMBL1663325 | 0.72 | CRHBP (0.63) | CRHBPCRHR2ABCB1ABCC1KCNMA1 | |
| Sulfuric Acid SCHEMBL6861269 | 0.72 | KMT2A (0.46) | THRBMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL28055312 | 0.72 | CRHBP (0.54) | CRHBPCRHR2ABCB1ABCC1THRB | |
| SCHEMBL2816974 | 0.71 | CRHBP (0.61) | CRHBPCRHR2ABCB1ABCC1THRB | |
| SCHEMBL1411626 | 0.70 | HSD17B10 (0.48) | MEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL30352851 | 0.70 | TDP1 (0.66) | CRHBPCRHR2ABCB1ABCC1THRB | |
| SCHEMBL3276362 | 0.70 | TDP1 (0.66) | CRHBPCRHR2ABCB1ABCC1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7166659-B2 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-23 | — | — | US | disclosed |
| US-7148274-B2 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-12-12 | — | — | US | disclosed |
| EP-1337520-B1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | CIBA SC HOLDING AG (CH) | 2004-12-15 | — | — | EP | disclosed |
| US-20040192927-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | PASTOR STEPHEN D (US) | 2004-09-30 | — | — | US | disclosed |
| US-20040157966-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | PASTOR STEPHEN D (US) | 2004-08-12 | — | — | US | disclosed |
| US-6774238-B2 | REACTING 5-SUBSTITUTED BENZOTRIAZOLE WITH ARYLBORONIC ACID IN PRESENCE OF PALLADIUM CATALYST; DEHALOGENATION; ARYLATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-08-10 | — | — | US | disclosed |
| US-20040092628-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparatiion thereof | PASTOR STEPHEN D (US) | 2004-05-13 | — | — | US | disclosed |
| US-6703510-B2 | MORE STABLE AND DURABLE; AUTOMOTIVE COATINGS, CANDLE WAX | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-03-09 | — | — | US | disclosed |
| US-20030213164-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | PASTOR STEPHEN D (US) | 2003-11-20 | — | — | US | disclosed |
| US-6649770-B1 | Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-11-18 | — | — | US | disclosed |
| EP-1337520-A1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | Ciba SC Holding AG (CH) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002042281-A1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192927-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | EBPL, DDT, AHR | CRHBP 3679/4885CRHR2 3210/4885ABCB1 1121/4885 |
| US-20030213164-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | EBPL, DDT, AHR | CRHBP 3679/4885CRHR2 3210/4885ABCB1 1121/4885 |
| US-20040092628-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparatiion thereof | AHR, PAH, CCNL2 | CRHBP 4051/4885CRHR2 3038/4885ABCB1 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.